Jarneborn, A.; Hu, Z.; Deshmukh, M.; Kopparapu, P.K.; Jin, T.
Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. Int. J. Mol. Sci. 2024, 25, 7456.
https://doi.org/10.3390/ijms25137456
AMA Style
Jarneborn A, Hu Z, Deshmukh M, Kopparapu PK, Jin T.
Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International Journal of Molecular Sciences. 2024; 25(13):7456.
https://doi.org/10.3390/ijms25137456
Chicago/Turabian Style
Jarneborn, Anders, Zhicheng Hu, Meghshree Deshmukh, Pradeep Kumar Kopparapu, and Tao Jin.
2024. "Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock" International Journal of Molecular Sciences 25, no. 13: 7456.
https://doi.org/10.3390/ijms25137456
APA Style
Jarneborn, A., Hu, Z., Deshmukh, M., Kopparapu, P. K., & Jin, T.
(2024). Tofacitinib Treatment Suppresses CD4+ T-Cell Activation and Th1 Response, Contributing to Protection against Staphylococcal Toxic Shock. International Journal of Molecular Sciences, 25(13), 7456.
https://doi.org/10.3390/ijms25137456